Details For Selected Brain Tumor Treatment
Sponsored By
Cedars-Siani Medical Center Brain Tumor Program
Please Click On The Above Banner For More Details
Braintumor Website

  • Last updated refers to the date when our listing for each treatment was last updated.
  • ID is our internal ID - starting with VT.
  • Min Karnofsky is a general guide to how well you have to function to use this treatment
  • For trials that also have a NCT number, you can click that number to pop up the listing from the clinicaltrials.gov website.
Back to New Treatments List Back to New Treatments List

Treatment Name: 2009-0759: A Phase 2 Open-Label Study of TPI 287 in Patients with Glioblastoma Multiforme That Has Recurred or Progressed Following Prior Therapy with Radiation plus Temozolomide
Keywords: TPI 287
Phase: Phase 2
Treatment ID#s: VT2024        
Age Group: Adults Only
Min Karnofsky Score: 60: Requires occasional assistance but is able to care for most of own needs
Conditions: Newly Diagnosed: N
Recurrent: Y
Prior Surgery is Allowed
Prior Radiation is Allowed
Prior Chemotherapy is Allowed
Recurrent or progressive glioblastoma
Last Updated: 05/11/2011
Tumor Types: Glioblastoma Multiforme
Comments: TPI 287 is a new anti-microbubule agent manufactured from naturally occurring taxanes, but modified to overcome resistance to taxanes and bind to mutant tubulin. In laboratory experiments it was greatly more active against multidrug-resistant cell lines than other compounds tested, and more active in animal model tumors of multidrug-resistant cell lines. Phase I testing showed little or no toxicity from TPI 287, which is able to cross the blood-brain barrier and achieve pharmacologically relevant levels.
Treatment Type: Chemotherapy.
Contact: MD Anderson Cancer Center
Jan Esenwein
Program Coordinator, Brain Tumor Program
Contact: Jan Esenwein or Marie Woodward
1515 Holcombe Blvd
Houston, TX 77030-
Phone:(713)745-2264
Fax: (713)794-4999
Click here to send an email
Website: www.mdanderson.org/diseases/braincancer/



Home | Brain Tumor Guide | Search | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure NovoTTF-100A | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us | Doctors Address Book



Copyright (c) 1993 - 2014 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites